Background-In previous studies on the effect of renal stenting on arterial hypertension, patients were selected mainly on the basis of angiographic parameters of the renal artery stenosis. The aim of the present study was to evaluate whether translesional pressure gradients could identify the patients with renal artery stenosis who might benefit from stenting. Methods and Results-A total of 53 consecutive hypertensive patients with unilateral RAS scheduled for renal artery intervention were recruited. Transstenotic pressure gradients were measured at baseline and during maximal hyperemia, before renal artery stenting. Twenty-four-hour ambulatory blood pressure measurements were performed in all patients before and 3 months after the intervention. Average reductions in systolic blood pressure and diastolic blood pressure at follow-up were Ϫ20Ϯ30 mm Hg and Ϫ2Ϯ12 mm Hg, respectively. At multivariate analysis, dopamine-induced mean gradient was the only independent predictor of the variations of both systolic blood pressure (regression coefficientϭϪ4.03, standard errorϭ1.11; PϽ0.001) and diastolic blood pressure (regression coefficientϭϪ3.11, standard errorϭ1.20; Pϭ0.009). Patients who showed a decline in systolic blood pressure from the baseline value Ͼ20 mm Hg were considered as "responders." The optimal cutoff for identification of "responders" was a dopamine-induced mean gradient Ն20 mm Hg (area under the curve, 0.77; 95% confidence interval, 0.64 to 0.90; Pϭ0.001). Conclusions-A dopamine-induced mean pressure gradient of Ն20 mm Hg is highly predictive of arterial hypertension improvement after renal stenting, and therefore this measurement is useful for appropriate selection of patients with arterial hypertension. (Circ Cardiovasc Interv. 2010;3:537-542.)
T he clinical evidence to show that renal artery stenting is effective in improving blood pressure and renal function is weak. [1] [2] [3] In these studies, patients were selected on the basis of angiographic parameters. The lack of a functional evaluation to ascertain the hemodynamic significance of the renal artery stenosis might account, at least in part, for the lack of improvement after stenting. Recent studies have indicated that translesional pressure gradient measurement might help to identify those patients with renal artery stenosis (RAS) in whom renal artery stenting would be beneficial in terms of hypertension improvement. 4, 5 However, the definition of improvement in hypertension used in these studies, as suggested by guidelines, 6 is based on definite threshold values and therefore may not be able to reflect the actual variations in blood pressure after treatment.
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Accordingly, the aim of the present study was to evaluate whether translesional pressure gradients, and in particular hyperemic pressure gradients, could identify the patients who might benefit from stenting for RAS.
Methods

Patient Population and Study Protocol
A total of 53 consecutive patients were selected for renal stenting because of the combination of the 2 following factors: (1) a persistent arterial hypertension as measured by cuff manometry at the outpatient clinic despite at least 2 antihypertensive medications and (2) the presence of an RAS of Ͼ50% diameter stenosis (DS) by visual estimate on a selective renal angiogram. Patients with severe renal dysfunction (creatinine clearance Ͻ30 mL/min) and previous renal artery intervention were excluded from the study. The local medical ethics committees approved the study and informed consent was obtained in all patients.
Hypertension was diagnosed in the presence of systolic blood pressure (SBP) Ͼ140 mm Hg and/or diastolic blood pressure (DBP) Ͼ90 mm Hg on at least 2 antihypertensive medications. Twentyfour-hour ambulatory blood pressure measurements (Mobil-OGraph, I.E.M. GmbH, Stolberg, Germany) were performed in all patients before and 3 months after the intervention. At the same time points, blood samples were taken and antihypertensive medications were recorded. Creatinine clearance was calculated according to the Cockroft-Gault formula and renal dysfunction was defined in the presence of a creatinine clearance Ͻ90 mL/min. 7
Invasive Renal Pressure Gradient Measurement
After quantitative renal angiography (CAAS II; Pie Medical Imaging, Maastricht, The Netherlands) was obtained, a 0.014-inch pressure wire (PressureWire Certus, RADI, St Jude Medical, Uppsala, Sweden) was advanced at least 4 cm distal to the renal stenosis for the assessment of distal renal pressure (P d ). Aortic pressure (P a ) was measured through the guiding catheter. Hyperemia was then induced first with papaverine (intrarenal bolus injection of 30 mg) and, after restoration of basal conditions, with dopamine (intrarenal bolus injection of 50 g/kg). 8 Systolic, diastolic, and mean pressure gradients as well as the P d /P a ratio were measured under resting conditions and after hyperemic stimuli. Renal artery stenting was then performed according to the standard technique. Procedural success was defined as a residual stenosis Ͻ30% in the target vessel.
Quantitative Renal Angiography
Percent DS was derived from quantitative renal angiography performed off-line and using the guide catheter as a scaling device by means of the QuantCor.QCA system (ACOM.PC 5.01, Siemens Medical Systems Inc, Malvern, Pa), based on the CAAS II system (Pie Medical Imaging, Maastricht, The Netherlands).
Statistics
Statistical analysis was carried out using SPSS 15.0 software (SPSS Inc, Chicago, Ill) and significance was defined as a probability value Correlations between translesional pressure gradients and variations in blood pressure at follow-up were tested with a linear regression univariate analysis. In the presence of a significant association (PϽ0.05), variables were entered into a multivariable linear regression model for the identification of independent predictors of blood pressure variations, using a generalized estimating equations approach to account for baseline values of blood pressure. A receiver-operating characteristic curve analysis was used to test the ability of translesional pressure gradients to discriminate between patients "responders" and "nonresponders." The optimal cutoff point was calculated by determining the value that provided the greatest sum of sensitivity and specificity.
Results
Study Sample
Clinical and procedural characteristics of study patients are listed in Table 1 . Preintervention arterial blood pressure monitoring showed 24-hour mean SBP and DBP values of 162Ϯ24 mm Hg and 81Ϯ12 mm Hg, respectively. The average creatinine clearance in the overall population was 61Ϯ23 mL/min and 23 patients (43%) had chronic renal dysfunction. Procedural and angiographic success was achieved in all patients with a reduction of the DS from 58Ϯ16% to 8Ϯ7%. Both papaverine and dopamine induced an increase in transstenotic pressure gradient (Table 2 ), but dopamine-induced hyperemia resulted in significantly higher diastolic gradient (DG) and mean gradient (MG), than papaverine-induced hyperemia (PϽ0.05 for both comparisons). No significant difference was observed in systolic gradient (SG) and in P d /P a .
Clinical follow-up was obtained in all patients. Three months after renal artery stenting, 24-hour mean blood pressure values were significantly lower compared with those recorded preintervention (SBP: 143Ϯ32 mm Hg, PϽ0.001 versus baseline; DBP: 78Ϯ13 mm Hg, Pϭ0.039 versus baseline; Figure 1 ). Average variations (difference between follow-up value and baseline value) in SBP and DBP were Ϫ20Ϯ30 mm Hg and Ϫ2Ϯ12 mm Hg, respectively (Figure 2 ). Univariate analysis showed that transstenotic pressure gradients and Pd/Pa ratios, as well as DS, significantly correlated to blood pressure changes at follow-up. At multivariable linear regression analysis, dopamine-induced MG was the only independent predictor of the variations of both SBP (regression coefficientϭϪ4.03, standard errorϭ1.11; PϽ0.001) and DBP (regression coefficientϭϪ3.11, standard errorϭ1.20; Pϭ0.009). The number of antihypertensive medications decreased significantly after renal artery stenting (3.2Ϯ1.2 versus 2.8Ϯ1.4; Pϭ0.005), whereas serum creatinine remained unchanged (1.25Ϯ0.53 mg/dL versus 1.21Ϯ0.51 mg/dL Pϭ0.206) as well as creatinine clearance (61Ϯ23 mL/min versus 62Ϯ23 mL/min; Pϭ0.454).
Responders Versus Nonresponders
At follow-up, 25 patients (47%) showed a decline in SBP from the baseline value Ͼ20 mm Hg (the average value in the overall population) with the same or reduced number of antihypertensive medications. These patients were considered as "responders." Receiver-operating characteristic curve analysis demonstrated that percent DS, SG, MG, and P d /P a both at baseline and during hyperemia could significantly discriminate between responders and nonresponders (Table 3) . Dopamine-induced MG had the highest value of area under the curve (AUC: 0.77; 95% confidence interval, 0.64 to 0.90; Pϭ0.001). A dopamineinduced MG Ն20 mm Hg was the optimal cutoff point to predict a favorable response of hypertension after renal stenting (sensitivity of 72% and specificity of 82%). A dopamine-induced MG Ͼ32 mm Hg was 95% predictive of a favorable response after renal stenting (Figure 3 ).
Quantitative Angiography Versus Pressure Gradients
A moderate correlation was found between baseline MG and percent DS (rϭ0.34, Pϭ0.013; Figure 4A ), and between dopamine-induced MG and percent DS (rϭ0.36, Pϭ0.009; Figure 4B ). Of note, among the whole population 31 (58%) patients presented a baseline mean gradient Ͻ9 mm Hg and 28 (53%) patients presented a dopamine-induced MG Ͻ20 mm Hg.
Discussion
Summary of the Present Findings
The present data indicate that patients in whom a substantial decrease in SBP will occur after renal artery stenting for RAS can be reliably identified on the basis of the mean gradient after an intrarenal bolus injection of dopamine. In contrast, the mere angiographic DS is a poor predictor of treatment success.
Previous Studies
The debate around clinical usefulness of renal artery stenting on top of optimal medical treatment is ongoing. 9 -11 Only a limited number of randomized studies have directly compared renal artery stenting with intensive medical treatment alone in patients with RAS, and none of these has shown a clear benefit in terms of cardiovascular and renal outcomes in favor of renal revascularization. [1] [2] [3] The main reasons for these results are related to the heterogeneity of the outcome measures of these studies and-even more so-to the heterogeneity of patients included in these studies. The definition for success has been widely variable ranging from blood pressure at 6 months 1 to changes in renal function 3 or event-free survival from cardiovascular and renal adverse events. 12 In agreement with guidelines, 6 some authors defined an improvement in arterial hypertension when DBP was Յ90 mm Hg and/or SBP was Յ140 mm Hg or in the presence of a reduction in DBP by at least 15 mm Hg with the same or reduced number of antihypertensive medications. 4, 5 However, in these studies, DBP was already around 90 mm Hg to start with in half of the patients; this precludes the evaluation of the actual efficacy of the treatment. In the present study, we evaluated blood pressure variations using 24-hour ambulatory blood pressure monitoring, the results of which are known to be markedly lower than those obtained from casual blood pressure measurements. 13, 14 Accordingly, in our patient population, only 25% of patients had an average DBP on 24-hour monitoring Ͼ90 mm Hg. This is the main reason why we elected to use criteria for improvement in hypertension, based on actual variations in blood pressure we identified in our population rather than those described by Rundback et al. 6 The renal function was not considered as an end point because the follow-up was very short. In most studies, comparing medical treatment with renal stenting, patients with refractory hypertension were included mainly on the basis of an RAS at angiography. Arterial narrowings are frequent in patients with hypertension so that it is often difficult to determine whether the RAS is the cause of the hypertension. Moreover, the actual severity of the RAS is often grossly overestimated by angiography. [15] [16] [17] [18] Therefore, it is likely that in previous randomized studies, [1] [2] [3] many patients have been included in whom no improvement could be expected from renal stenting. The present data indicate that in more than half of patients selected for renal stenting on the basis of a RAS of Ͼ50% by subjective evaluation of the angiogram, dopamine-induced pressure gradient was Ͻ20 mm Hg.
Function Versus Morphology of the RAS
Measuring a pressure difference across the renal artery refers to the very mechanisms by which RAS is supposed to induce hypertension: A decrease in perfusion pressure of the juxtaglomerular apparatus induces a local release of rennin, which in turn triggers the renin-angiotensin system. In addition, a pressure gradient is proportional to the flow across the stenosis and thus provides indirect information about the renal parenchymal resistances. It might be speculated thatfor a given degree of stenosis-when parenchymal resistance is high, hyperemic flow will be low. In turn, hyperemic gradient will be small, suggesting that little effect can be expected from renal stenting. In contrast, in the case of moderate stenosis with a normal renal parenchyma, a high hyperemic flow will elicit a large gradient, indicating that renal stenting might be clinically useful. Nevertheless, it should be noted that Zeller et al 19 have reported that patients with more severe resistance indices actually benefit more from revascularization.
Resting Versus Hyperemic Pressure Measurements
Previous studies investigated pharmacologically induced renal hyperemia. 20, 21 In these studies, hyperemia has been proposed as a way to increase the accuracy of the pressure measurements, as is the case in the coronary arteries. The hyperemic stimulus used in previous studies was papaverine. 4, 5, 16, 22 Yet, Manoharan et al have shown that the most powerful renal vasodilator was dopamine (50 g/kg as an intrarenal bolus). In line with these findings, dopamine appeared to induce significantly higher mean transstenotic gradients in the present study. These larger gradients translated in a slightly better predictive value for dopamine than for papaverine. Nevertheless, it should be observed that renal hyperemia is modest (flow reserve of 1.8) as compared with the myocardium (flow reserve of 5 to 6) and with the peripheral muscles (flow reserve of 8 to 10). Teleologically, this makes sense as the kidney "aims" at maintaining filtration pressure constant (be it at the cost of renal blood flow), 23 whereas the heart "aims" at maintaining blood flow constant (be it at the cost of perfusion pressure). The limited renal hyperemia also explains why the predictive value of mean resting gradient is almost as good as that of mean dopamineinduced gradient.
In conclusion, these data suggest that renal stenting is an effective means of treating hypertension in patients with unilateral RAS selected on the basis of renal artery hemodynamics. The present study indicates that a dopamine-induced mean pressure gradient of Ն20 mm Hg is highly predictive of a marked improvement of the arterial hypertension after renal stenting and therefore that this measurement is useful for appropriate individual decision-making in patients with arterial hypertension.
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